Eric Tomlinson, D.Sc., Ph.D., Wake Forest Baptist Medical Center’s chief innovation officer and the president of Wake Forest Innovation Quarter, will make a presentation, “Accelerating the Transformation of Research Discoveries,” at the 2014 BIO International Convention in San Diego.
The convention, billed as the largest global event for the biotech industry, will be held June 23-26 at the San Diego Convention Center. It is organized by the Biotechnology Industry Organization, an international trade association based in Washington, D.C.
Tomlinson’s BIO Business Forum presentation on Tuesday, June 24, will focus on how Wake Forest Innovations, Wake Forest Baptist’s commercialization arm, partners with pharmaceutical, biotechnology and medical device companies to transform scientific discoveries into high-value health care products.
“The BIO convention is attended by top executives and decision-makers in biotechnology, pharmaceuticals and related industries from around the world,” Tomlinson said. “So it’s an ideal setting to describe our services and our commitment to accelerating the transformation of both our own research discoveries and those of industry into viable commercial products that will save lives and improve health care worldwide.”
In addition to Tomlinson, Wake Forest Innovations will be represented at the convention by Chris Jerome, Ph.D., associate vice president for contract research & development services; Mark Furth, Ph.D., executive director of product innovation services; Daniel Yohannes, Ph.D., associate director of product innovation services; Michael Batalia, Ph.D., executive director of product commercialization services; and Stephen Susalka, Ph.D., associate director of product commercialization services. The five are scheduled to make presentations in the North Carolina Pavilion at the convention.